Association of a HOXB13 variant with breast cancer.
作者信息
Alanee Shaheen, Couch Fergus, Offit Kenneth
出版信息
N Engl J Med. 2012 Aug 2;367(5):480-1. doi: 10.1056/NEJMc1205138.
Abstract
摘要
相似文献
1
Association of a HOXB13 variant with breast cancer.
N Engl J Med. 2012 Aug 2;367(5):480-1. doi: 10.1056/NEJMc1205138.
2
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.
Breast Cancer Res Treat. 2012 Dec;136(3):907-9. doi: 10.1007/s10549-012-2295-y. Epub 2012 Oct 26.
3
Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
Prostate. 2020 May;80(6):463-470. doi: 10.1002/pros.23960. Epub 2020 Feb 10.
4
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.
Clin Cancer Res. 2008 Sep 15;14(18):5864-8. doi: 10.1158/1078-0432.CCR-08-0619.
5
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Sci Rep. 2016 Jul 18;6:30026. doi: 10.1038/srep30026.
6
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
Breast Cancer Res Treat. 2008 Jan;107(2):225-34. doi: 10.1007/s10549-007-9541-8. Epub 2007 Apr 24.
7
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):452-60. doi: 10.1158/1055-9965.EPI-12-1000-T. Epub 2013 Jan 4.
8
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.
J Clin Oncol. 2007 Feb 20;25(6):662-8. doi: 10.1200/JCO.2006.07.3676.
9
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7. doi: 10.1158/1078-0432.CCR-05-1263.
10
Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.
Carcinogenesis. 2008 Jul;29(7):1459-65. doi: 10.1093/carcin/bgn115. Epub 2008 May 21.
引用本文的文献
1
HOXB13 in cancer development: molecular mechanisms and clinical implications.
Front Med. 2025 Mar 11. doi: 10.1007/s11684-024-1119-x.
2
Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4.
Cell Commun Signal. 2024 Dec 19;22(1):611. doi: 10.1186/s12964-024-02000-2.
3
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Sci Rep. 2020 Jun 16;10(1):9688. doi: 10.1038/s41598-020-65665-y.
4
The Role of HOX Transcription Factors in Cancer Predisposition and Progression.
Cancers (Basel). 2019 Apr 12;11(4):528. doi: 10.3390/cancers11040528.
5
The Enigmatic HOX Genes: Can We Crack Their Code?
Cancers (Basel). 2019 Mar 7;11(3):323. doi: 10.3390/cancers11030323.
6
Role of HOX Genes in Stem Cell Differentiation and Cancer.
Stem Cells Int. 2018 Jul 22;2018:3569493. doi: 10.1155/2018/3569493. eCollection 2018.
7
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
Cancer Discov. 2016 Nov;6(11):1267-1275. doi: 10.1158/2159-8290.CD-16-0487. Epub 2016 Sep 21.
8
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Sci Rep. 2016 Jul 18;6:30026. doi: 10.1038/srep30026.
9
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Am J Hum Genet. 2016 May 5;98(5):801-817. doi: 10.1016/j.ajhg.2016.02.024.
10
HOX genes: Major actors in resistance to selective endocrine response modifiers.
Biochim Biophys Acta. 2016 Apr;1865(2):105-10. doi: 10.1016/j.bbcan.2016.01.003. Epub 2016 Jan 22.
本文引用的文献
1
Germline mutations in HOXB13 and prostate-cancer risk.
N Engl J Med. 2012 Jan 12;366(2):141-9. doi: 10.1056/NEJMoa1110000.
2
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.
Breast Cancer Res. 2010;12(4):R53. doi: 10.1186/bcr2612. Epub 2010 Jul 22.
3
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
Cancer Cell. 2004 Jun;5(6):607-16. doi: 10.1016/j.ccr.2004.05.015.
4
In vivo expression of the whole HOX gene network in human breast cancer.
Eur J Cancer. 2003 Jan;39(2):257-64. doi: 10.1016/s0959-8049(02)00599-3.
Zotero 插件